vs

Side-by-side financial comparison of FIRST INDUSTRIAL REALTY TRUST INC (FR) and Penumbra Inc (PEN). Click either name above to swap in a different company.

Penumbra Inc is the larger business by last-quarter revenue ($385.4M vs $194.8M, roughly 2.0× FIRST INDUSTRIAL REALTY TRUST INC). FIRST INDUSTRIAL REALTY TRUST INC runs the higher net margin — 75.9% vs 12.3%, a 63.6% gap on every dollar of revenue. On growth, Penumbra Inc posted the faster year-over-year revenue change (22.1% vs 10.0%). Over the past eight quarters, Penumbra Inc's revenue compounded faster (17.6% CAGR vs 8.9%).

First Potomac Realty Trust was a real estate investment trust that invested in industrial properties and business parks in the suburbs of the Washington metropolitan area. In 2017, it was acquired by Government Properties Income Trust.

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

FR vs PEN — Head-to-Head

Bigger by revenue
PEN
PEN
2.0× larger
PEN
$385.4M
$194.8M
FR
Growing faster (revenue YoY)
PEN
PEN
+12.1% gap
PEN
22.1%
10.0%
FR
Higher net margin
FR
FR
63.6% more per $
FR
75.9%
12.3%
PEN
Faster 2-yr revenue CAGR
PEN
PEN
Annualised
PEN
17.6%
8.9%
FR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FR
FR
PEN
PEN
Revenue
$194.8M
$385.4M
Net Profit
$147.9M
$47.3M
Gross Margin
68.0%
Operating Margin
15.4%
Net Margin
75.9%
12.3%
Revenue YoY
10.0%
22.1%
Net Profit YoY
179.7%
40.6%
EPS (diluted)
$1.08
$1.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FR
FR
PEN
PEN
Q1 26
$194.8M
Q4 25
$188.4M
$385.4M
Q3 25
$181.4M
$354.7M
Q2 25
$180.2M
$339.5M
Q1 25
$177.1M
$324.1M
Q4 24
$175.6M
$315.5M
Q3 24
$167.6M
$301.0M
Q2 24
$164.1M
$299.4M
Net Profit
FR
FR
PEN
PEN
Q1 26
$147.9M
Q4 25
$78.8M
$47.3M
Q3 25
$65.3M
$45.9M
Q2 25
$55.2M
$45.3M
Q1 25
$48.1M
$39.2M
Q4 24
$68.4M
$33.7M
Q3 24
$99.4M
$29.5M
Q2 24
$51.3M
$-60.2M
Gross Margin
FR
FR
PEN
PEN
Q1 26
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Operating Margin
FR
FR
PEN
PEN
Q1 26
Q4 25
34.6%
15.4%
Q3 25
37.0%
13.8%
Q2 25
31.7%
12.0%
Q1 25
31.2%
12.4%
Q4 24
40.1%
13.6%
Q3 24
62.6%
11.7%
Q2 24
31.8%
-27.0%
Net Margin
FR
FR
PEN
PEN
Q1 26
75.9%
Q4 25
41.8%
12.3%
Q3 25
36.0%
12.9%
Q2 25
30.6%
13.3%
Q1 25
27.2%
12.1%
Q4 24
39.0%
10.7%
Q3 24
59.3%
9.8%
Q2 24
31.3%
-20.1%
EPS (diluted)
FR
FR
PEN
PEN
Q1 26
$1.08
Q4 25
$0.60
$1.20
Q3 25
$0.49
$1.17
Q2 25
$0.42
$1.15
Q1 25
$0.36
$1.00
Q4 24
$0.51
$0.88
Q3 24
$0.75
$0.75
Q2 24
$0.39
$-1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FR
FR
PEN
PEN
Cash + ST InvestmentsLiquidity on hand
$186.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.9B
$1.4B
Total Assets
$5.8B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FR
FR
PEN
PEN
Q1 26
Q4 25
$78.0M
$186.9M
Q3 25
$33.5M
$321.0M
Q2 25
$34.9M
$421.8M
Q1 25
$35.7M
$376.1M
Q4 24
$44.5M
$324.4M
Q3 24
$47.1M
$280.5M
Q2 24
$38.5M
$288.3M
Stockholders' Equity
FR
FR
PEN
PEN
Q1 26
$2.9B
Q4 25
$2.7B
$1.4B
Q3 25
$2.7B
$1.4B
Q2 25
$2.6B
$1.3B
Q1 25
$2.7B
$1.2B
Q4 24
$2.7B
$1.2B
Q3 24
$2.6B
$1.1B
Q2 24
$2.6B
$1.2B
Total Assets
FR
FR
PEN
PEN
Q1 26
$5.8B
Q4 25
$5.7B
$1.8B
Q3 25
$5.5B
$1.7B
Q2 25
$5.5B
$1.7B
Q1 25
$5.4B
$1.6B
Q4 24
$5.3B
$1.5B
Q3 24
$5.2B
$1.5B
Q2 24
$5.2B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FR
FR
PEN
PEN
Operating Cash FlowLast quarter
$86.5M
Free Cash FlowOCF − Capex
$68.0M
FCF MarginFCF / Revenue
17.7%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FR
FR
PEN
PEN
Q1 26
Q4 25
$461.3M
$86.5M
Q3 25
$124.6M
$58.3M
Q2 25
$126.1M
$44.9M
Q1 25
$88.6M
$49.0M
Q4 24
$352.5M
$51.1M
Q3 24
$105.5M
$56.5M
Q2 24
$107.7M
$22.6M
Free Cash Flow
FR
FR
PEN
PEN
Q1 26
Q4 25
$68.0M
Q3 25
$42.0M
Q2 25
$29.4M
Q1 25
$35.5M
Q4 24
$45.7M
Q3 24
$51.0M
Q2 24
$18.1M
FCF Margin
FR
FR
PEN
PEN
Q1 26
Q4 25
17.7%
Q3 25
11.8%
Q2 25
8.7%
Q1 25
11.0%
Q4 24
14.5%
Q3 24
16.9%
Q2 24
6.0%
Capex Intensity
FR
FR
PEN
PEN
Q1 26
Q4 25
4.8%
Q3 25
4.6%
Q2 25
4.6%
Q1 25
4.2%
Q4 24
1.7%
Q3 24
1.8%
Q2 24
1.5%
Cash Conversion
FR
FR
PEN
PEN
Q1 26
Q4 25
5.85×
1.83×
Q3 25
1.91×
1.27×
Q2 25
2.28×
0.99×
Q1 25
1.84×
1.25×
Q4 24
5.15×
1.52×
Q3 24
1.06×
1.91×
Q2 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FR
FR

Segment breakdown not available.

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

Related Comparisons